Incyte develops and sells prescription medicines, mainly for blood cancers and other conditions. Analyst consensus is Buy, based on the latest ratings from 14 firms (9 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in INCY, 0% of them bullish and 100% bearish. In the past 30 days there were 1 dark pool print.
Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 30 | Wells Fargo | Target lowered | Hold | |
| Oct 30 | RBC Capital | Target raised | Hold | |
| Oct 30 | Barclays | Target raised | Buy | |
| Oct 30 | Evercore ISI Group | Maintained | Hold | |
| Oct 30 | Oppenheimer | Upgrade | Buy |
Whale Options Flow
90DNo whale options trades in INCY in the last 90 days.
Dark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INCY is in one of them and how their past INCY trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered INCY in an article yet. Here's the latest on the wider market.
INCY Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Ro KhannaD · CA | Buy | $1K – $15K | Sep 4, 2026 | Oct 9, 2026 | 35 d |
| Ro KhannaD · CA | Buy | $1K – $15K | May 19, 2025 | Jun 12, 2025 | 24 d |
| Rob BresnahanR · PA | Sell | $1K – $15K | May 15, 2025 | May 31, 2025 | 16 d |
| Ro KhannaD · CA | Sell | $1K – $15K | Feb 18, 2025 | Mar 5, 2025 | 15 d |
| Ro KhannaD · CA | Buy | $1K – $15K | Nov 15, 2024 | Dec 5, 2024 | 20 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Incyte
Incyte is a biopharmaceutical company based in Wilmington, Delaware. It discovers, develops and sells prescription medicines, mainly for blood cancers and other conditions, including a topical cream. Physicians prescribe its products to patients, and insurers and other payors decide on coverage. Some of its products are also developed and sold with partners, including Novartis and Lilly.
- Headquarters
- Wilmington, DE
- Founded
- 2001
- Website
- incyte.com ↗